MedTrace Logo

Assessment of sTREM-1 as a Diagnostic Marker in Patients With Neutropenic Fever

NCT01034059 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2009-12-17

No results posted yet for this study

Summary

The soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) was an established biomarker useful for infection in non-neutropenic patients. In this study, we tested sTREM-1 in the patients with neutropenic fever. Pro-calcitonin (PCT) and C-reactive protein (CRP) were also measured. We planned to investigate and explore the role of sTREM-1 in early diagnosis of infection in patients with neutropenic fever.

Conditions

  • Neutropenic Fever

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Szu-Chun Hsu, MD · Department of Laboratory Medicine, National Taiwan University Hospital and College of Medicine, Taipei

Eligibility

Min Age
18 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-06-30
Completion
2009-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01034059 on ClinicalTrials.gov